Search
Support us
View show page
JACC Specialty Journals
Oncologic Benefits and Cardiovascular Risks of Pembrolizumab: Insights From a Nationwide Lung Adenocarcinoma Cohort | JACC: Asia
Oct 6, 2026
4:20
Save
Follow
Share
Heart Health
Cancer Immunotherapy
Pulmonology
Episode Description
Commentary by Dr. Koohyar Ahmadzadeh.
Listen On
How to rate & review on Apple Podcasts
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows